Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation
Nature Neuroscience2007Vol. 10(3), pp. 280–282
Citations Over TimeTop 10% of 2007 papers
Geeske M. van Woerden, K. Dillon Harris, Mohammad Reza Hojjati, Richard M. Gustin, Shenfeng Qiu, Rogerio de Avila Freire, Yong-hui Jiang, Ype Elgersma, Edwin J. Weeber
Related Papers
- → UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome(2021)59 cited
- → Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome(2023)26 cited
- → Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome(2022)3 cited
- → Development of an ASO therapy for Angelman syndrome by targeting an evolutionarily conserved region at the start of the UBE3A-AS transcript(2021)2 cited
- → Decision letter: Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome(2022)